Literature DB >> 1335569

Replication inhibition by nucleoside analogues of a recombinant Autographa californica multicapsid nuclear polyhedrosis virus harboring the herpes thymidine kinase gene driven by the IE-1(0) promoter: a new way to select recombinant baculoviruses.

F Godeau1, C Saucier, P Kourilsky.   

Abstract

The expression of the thymidine-thymidylate kinase (HSV1-TK), (ATP: thymidine 5'-phosphotransferase; EC 2.7.1.21) of herpes simplex virus type 1 endows the host cell with a conditional lethal phenotype which depends on the presence of nucleoside analogues metabolized by this enzyme into toxic inhibitors of DNA replication. To generate a recombinant baculovirus that could be selected against by nucleoside analogs, the HSV1-tk coding sequence was placed under the control of the Autographa californica multicapsid nuclear polyhedrosis virus (AcMNPV) immediate early promoterm IE-1(0), and this construction was introduced via homologous recombination into the polyhedrin locus of AcMNPV. Two recombinant baculoviruses harboring this gene construct at the polyhedrin locus were isolated and tested for their ability to replicate in the presence of various concentrations of the nucleoside analog 9-(1,3-Dihydroxy-2-propoxymethyl)guanine (Ganciclovir). Neither Sf9 lepidopteran cell viability nor replication of wild type or beta-Galactosidase-expressing recombinant AcMNPVs were affected by concentrations of Ganciclovir up to 100 microM. In contrast, replication of the recombinant AcMNPV virus harboring the HSV1-tk gene was inhibited by Ganciclovir in a dose-dependent manner. The inhibition was detectable at 2 microM and complete at 100 microM. This property was exploited in model isolations aimed at purifying new recombinant viruses having lost this counter-selectable gene marker as a result of homologous recombination at the polyhedrin locus after cotransfection of the viral DNA with a replacement vector. After being propagated in the presence of Ganciclovir, the progeny of such co-transfections contained over 85% recombinant viruses, demonstrating that counter-selection of parental HSV1-tk-containing viruses by Ganciclovir constitutes a novel approach for recombinant baculovirus isolation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335569      PMCID: PMC334511          DOI: 10.1093/nar/20.23.6239

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  38 in total

1.  Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene.

Authors:  J Vialard; M Lalumière; T Vernet; D Briedis; G Alkhatib; D Henning; D Levin; C Richardson
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

Review 2.  Expression of foreign genes in insects using baculovirus vectors.

Authors:  S Maeda
Journal:  Annu Rev Entomol       Date:  1989       Impact factor: 19.686

3.  Novel regulatory properties of the IE1 and IE0 transactivators encoded by the baculovirus Autographa californica multicapsid nuclear polyhedrosis virus.

Authors:  G R Kovacs; L A Guarino; M D Summers
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Transgenic mice with inducible dwarfism.

Authors:  E Borrelli; R A Heyman; C Arias; P E Sawchenko; R M Evans
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

5.  Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors.

Authors:  P A Kitts; M D Ayres; R D Possee
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

6.  Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency.

Authors:  R A Heyman; E Borrelli; J Lesley; D Anderson; D D Richman; S M Baird; R Hyman; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Targeting of an inducible toxic phenotype in animal cells.

Authors:  E Borrelli; R Heyman; M Hsi; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

8.  Efficient, low-cost protein factories: expression of human adenosine deaminase in baculovirus-infected insect larvae.

Authors:  J A Medin; L Hunt; K Gathy; R K Evans; M S Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  High level expression of nonfused foreign genes with Autographa californica nuclear polyhedrosis virus expression vectors.

Authors:  V A Luckow; M D Summers
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

10.  A cytopathological investigation of Autographa californica nuclear polyhedrosis virus p10 gene function using insertion/deletion mutants.

Authors:  G V Williams; D Z Rohel; J Kuzio; P Faulkner
Journal:  J Gen Virol       Date:  1989-01       Impact factor: 3.891

View more
  5 in total

1.  Construction of baculovirus recombinants.

Authors:  P A Kitts
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Obtaining a functional recombinant anti-rhesus (D) antibody using the baculovirus-insect cell expression system.

Authors:  L Edelman; C Margaritte; H Chaabihi; E Monchâtre; D Blanchard; A Cardona; F Morin; G Dumas; S Petres; M Kaczorek
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  Expression of p24 gag protein of bovine leukemia virus in insect cells and its use in immunodetection of the disease.

Authors:  Alejandra Larsen; Ester Teresa Gonzalez; María Soledad Serena; María Gabriela Echeverría; Eduardo Mortola
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

4.  The 35-kilodalton protein gene (p35) of Autographa californica nuclear polyhedrosis virus and the neomycin resistance gene provide dominant selection of recombinant baculoviruses.

Authors:  R A Lerch; P D Friesen
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

5.  Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43.

Authors:  Thomas Mourez; Astrid Vabret; Yang Han; Julia Dina; Loïc Legrand; Sandrine Corbet; François Freymuth
Journal:  J Virol Methods       Date:  2006-10-31       Impact factor: 2.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.